Exposure of monkeys to aerosols of influenza virus followed later by aerosols of Diplococcus pneumoniae resulted in persistence of the bacteria in the upper respiratory tract for an average of 28 days. Examination of selected tissues for pneumococci revealed that pneumococci were widely disseminated throughout the respiratory tract at 3 and 7 days after exposure, but were cleared from lower respiratory tissues and were found mainly in tonsils, oropharynx, and posterior nasopharynx after 14 days.
Bacterial pneumonia after influenza virus infection was recognized as an important medical problem long before the etiology of influenza was identified, and this sequence of infections still constitutes a serious disease syndrome (14) . It is well established that the organisms isolated most frequently from patients with postinfluenzal pneumonia are Diplococcus pneumoniae and Staphylococcus aureus (3, 7, 15, 16, 18) . In spite of the importance of this disease syndrome, most published reports have dealt with clinical findings of patients involved in epidemics rather than with experiments dealing with laboratory animals. This paucity of experimental data may be attributed to the lack of a suitable animal model and to the difficulty of employing aerosol exposures to establish sequential infection with influenza virus and gram-positive bacteria. Some investigators, however, have utilized influenza virus to study sequential infection in laboratory mice. Francis reported that synergism occurred between influenza virus and Haemophilus influenza after intranasal instillation only if the bacteria were administered at least 24 h after the virus (5). Gerone and co-workers (6) reported that aerosol-induced pneumococcal infection after influenza virus exposure to aerosols depressed viral antibody formation and terminated in fatal pneumococcal pneumonia. Synergistic activity of inhaled influenza virus and pneumococci or streptococci has also been described by others (8, 9; Use of subhuman primates for similar studies has been limited, primarily because conditions for establishing clinical influenza in monkeys are poorly understood. Several decades ago, however, Wilson and co-workers (19) described clinical illness in 5 of 11 monkeys that were challenged intranasally with Streptococcus hemolyticus 4 to 17 days after receiving the PR-8 strain of influenza virus, and suggested that the prior exposure to influenza caused alterations in both humoral and cellular defense mechanisms.
We have taken advantage of improved capability for control of dosage and particle size of aerosols of microorganisms to examine various facets of the effect of viral infection on the persistence of D. pneumoniae in various tissues of primates.
MATERIALS AND METHODS
Influenza virus. The Aichi/2/68 strain of type A (H3N2) influenza virus was propagated by allantoic cavity inoculation of 10-to 13-day-old embryonated eggs. Procedures for growth, harvest, and storage have been described previously (2 Aerosol dissemination and particle size estimation. The procedures and apparatus employed for aerosol dissemination and particle size estimation have been described previously (2) . The Collison atomizer was employed for dissemination of smallparticle aerosols of influenza virus (median diameter, 2.0 ,m), and the Dautrebande nebulizer (4) was substituted to disseminate pneumococcal aerosols (median diameter, 2.4 gm) because the viscosity of suspensions of pneumococci was sufficiently high to produce aerosol particles of 3.5-Mm diameter. The size distribution of the aerosol particles was estimated by the method of Malligo and Idoine (13) .
Experimental animals. Macaca mulatta (rhesus monkeys), weighing from 2.5 to 4.5 kg, were conditioned for 60 days before experimental use. They were allowed free access to water and commercial monkey chow after sampling procedures were completed each morning. Methods for aerosol exposure, estimation of number of organisms inhaled, and collection of blood and nasopharyngeal samples have been described previously (2).
Serological techniques. Antiinfluenza hemagglutination inhibition titers were measured with guinea pig erythrocytes in microtiter plates, and immunoglobulin determinations were performed by the Mancini technique (2) .
A modification of the passive hemagglutination test described by Ammann and Pelger (1) was employed to measure antibody to type 1 D. pneumoniae. Pooled rhesus monkey erythrocytes, substituted for human type 0 cells, were complexed to purified type 1 pneumococcal polysaccharide with chromic chloride.
Organism isolation. Mouse inoculation was employed to detect the presence of D. pneumoniae in nasopharyngeal washings and tissue samples. A volume (0.5 ml) of each washing was inoculated intraperitoneally into each of five mice; 0.1 ml of heart blood from mice that died or were moribund within 72 h was spread on a blood agar plate. After an optochin disk (Difco Laboratories, Detroit, Mich.) was placed on the surface, the plate was incubated for 24 h at 37 C. The presence of pneumococci was confirmed by characteristic growth, alpha hemolysis, and by a zone of inhibition around the disk.
Influenza virus was isolated by inoculation of embryonated eggs with nasal washings that had been incubated for 1 h at room temperature with 100 U of penicillin and 100 Mg of streptomycin per ml. After 48 h of incubation at 35 C, the presence of the virus in allantoic fluid was determined by standard hemagglutination titrations.
Radiographic examination. Where indicated, anterior-posterior and left-lateral radiographs of the thorax were obtained from monkeys that had been anesthetized with ketamine hydrochloride (Ketaset; Bristol Laboratories, Syracuse, N.Y.).
INFECT. IMMUNITY
Collection and processing to tissue samples.
Monkeys were sacrificed by intravenous inoculation of 1.2 g of pentobarbital. The chest was opened aseptically, and sections of the diaphragmatic lobe of the left lung, secondary bronchus adjacent to it, a bronchial lymph node adjacent to the left main bronchus, a piece of the middle third of the trachea, larynx, oropharynx, right tonsil, and posterior and anterior nasopharynx were excised and placed in 5.0 ml of heart infusion broth. Nasal mucosa was obtained with a stiff test tube brush that was immersed in broth. An effort was made to remove a sample of the same size from each monkey. The right lung was perfused with formalin, and a sample equivalent to each described above was removed and placed in formalin for histopathological examination. The tissues were ground in Ten-Broeck grinders, and 0.5 ml of each was inoculated into five mice for isolation of pneumococci as previously described. The number of mice dying in each group, therefore, gave a rough approximation of the number of bacteria contained in each sample.
RESULTS
Preliminary experiments. Twelve monkeys were exposed to aerosols of influenza virus; one group of three monkeys served as virus infection controls, and three groups of three monkeys each were exposed to aerosols of pneumococci 3, 7, or 10 days, respectively, after exposure to the virus. Three additional monkeys served as pneumococcal infection controls and two monkeys received no treatment. On the 5th and 6th days prior to virus exposure and from day 1 (24 h after exposure) through day 9, rectal temperatures were recorded, blood samples were obtained for serology, total and differential leukocyte counts, and hematocrit, and nasopharyngeal washings were collected for immunoglobulin A (IgA) and IgG determinations and for isolation of virus and D. pneumoniae. Samples were obtained on days 11, 13 and 17 postexposure for immunoglobulin assay and serology, and daily for isolation of virus and bacteria, until the organisms could no longer be isolated. Pneumococcal recovery from the 3-, 7-, and 10-day sequentially exposed groups of three monkeys each ranged from 7 to 99 days (mean of 28), whereas the bacterial recovery from the pneumococcal control group ranged only from 2 to 11 days (mean of 7). Leukocyte counts, hematocrit levels, and rectal temperatures showed no significant change.
Geometric mean values for antipneumococcal hemagglutination inhibition titers were very low, but the response of the 3-day group appeared earlier and rose to higher levels than the control group, suggesting that prior influenza virus infection either increased host responsiveness to pneumococcal antigen or resulted in (10), who have shown that pneumonia due to gram-negative bacilli in seriously ill patients in hospitals is caused by aspiration of bacteria from the pharynx. Our most important observation is the persistence of bacteria in the upper respiratory tract. The occurrence of this reaction, if it occurred in humans after mild respiratory virus infection, could constitute one means by which a carrier state may be established. In contrast, these studies failed to yield supportive evidence fot the commonly accepted explanation for development of pneumococcal pneumonia subsequent to severe influenza in human patients, whereas it has been postulated that influenza virus infection causes necrosis of the tracheo-bronchial epithelium and edema (8, 9, 11) , and thereby provides a site in which bacteria can multiply relatively undisturbed by host clearance mechanisms. We cannot eliminate the possibility that such a reaction occurred in the upper respiratory tract, but it was not evident histologically at any time of sampling. It is equally possible, however, that some other mechanism, directly or indirectly, is responsible for alteration of the microenvironment of the tonsils and oropharynx in such a way as to favor bacterial persistence.
